958253-46-8 Usage
Uses
Used in Pharmaceutical Industry:
2,4-bisbenzyloxy-5-bromobenzoyl chloride is utilized as a key intermediate in the synthesis of pharmaceuticals for its ability to facilitate the creation of complex organic molecules that can exhibit therapeutic properties.
Used in Agrochemical Industry:
In the agrochemical sector, 2,4-bisbenzyloxy-5-bromobenzoyl chloride serves as a crucial component in the development of new agrochemicals, leveraging its reactivity to form compounds with pesticidal or herbicidal activity.
Used in Organic Synthesis:
2,4-bisbenzyloxy-5-bromobenzoyl chloride is employed as a reagent in organic synthesis, where its unique structure and reactivity contribute to the formation of a wide array of organic compounds for various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 958253-46-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,8,2,5 and 3 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 958253-46:
(8*9)+(7*5)+(6*8)+(5*2)+(4*5)+(3*3)+(2*4)+(1*6)=208
208 % 10 = 8
So 958253-46-8 is a valid CAS Registry Number.
958253-46-8Relevant academic research and scientific papers
TRIAZOLE DERIVATIVES II
-
Page/Page column 17, (2010/02/17)
Novel triazole derivatives of the formula (I) in which R1—R6 and Y have the meanings indicated in Claim 1, are HSP90 inhibitors and can be used for the preparation of a medicament for the treatment of diseases in which the inhibition, regulation and/or modulation of HSP90 plays a role.
TRIAZOLE DERIVATIVE AS AN HSP 90 INHIBITOR
-
Page/Page column 15-16, (2010/05/13)
5-[4-(2-Methylphenyl)-3-hydroxy-4H-1,2,4-triazol-5-yl]-2,4-dihydroxy-N-methyl-N-butylbenzamide is an HSP90 inhibitor and can be used for the preparation of a medicament for the treatment of diseases in which the inhibition, regulation and/or modulation of HSP90 plays a role.
TRIAZOLE DERIVATIVES
-
Page/Page column 92, (2008/06/13)
The invention relates to novel triazole derivatives of formula (I) wherein R1 - R6 and Y have the designations cited in patent claim 1. Said derivatives are HSP90 inhibitors, and can be used to produce a medicament for treating diseases wherefore the inhibition, regulation and/or modulation of HSP90 plays an important role.
